| Course | DNP 825 Population Management |
|---|---|
| Topic | Topic 7 |
| Paper type | Population intervention proposal |
| Length | About 1,020 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | October 2026 |
Free sample paper for DNP 825 Topic 7
A Proposal the Committee Can Approve or Decline: Home Blood Pressure Telemonitoring With Pharmacist Titration for 400 of 2,450 Adults With Persistently Uncontrolled Hypertension
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
DNP-825: Population Management
Topic 7 Assignment
[Instructor Name]
September 13, 2027
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
A Proposal the Committee Can Approve or Decline: Home Blood Pressure Telemonitoring With Pharmacist Titration for 400 of 2,450 Adults With Persistently Uncontrolled Hypertension
The Population, Defined to a Count
The proposal is for adults aged 18 to 80 who are attributed to the system's primary care panels, have diagnosed hypertension and whose last two office readings, at least 30 days apart, were 140/90 mm Hg or higher. Patients receiving dialysis, pregnant patients and patients enrolled in hospice are excluded. On the registry pull of August 31, 2027, this definition yields 2,450 adults across the 11 clinics. They are the persistently uncontrolled core of the 5,400 diagnosed patients whose last reading was above target, and in the past year they averaged 3.1 office visits each without reaching control. The pilot will enroll 400 of them at four clinics, chosen because those clinics have the largest numbers and a clinical pharmacist already on site part of the week.
The Intervention: Who Does What, to Whom and How Often
At enrollment, a medical assistant gives each patient a validated upper-arm home monitor that transmits readings automatically through a cellular hub, with no smartphone needed, and shows the patient the routine: on three days a week, a pair of readings after waking and another pair before bed. The readings flow to a clinical pharmacist, who is authorized to adjust therapy by a protocol the four clinics' primary care physicians have signed. Every two weeks, the pharmacist reviews each patient's home average and calls the patient: to start or adjust medication according to the agreement's protocol, order a basic metabolic panel after changes to drugs that affect potassium or kidney function, and check side effects and adherence. Once a patient's home average holds under 135/85 mm Hg, the home reading the 2017 guideline pairs with an office value below 140/90 (Whelton et al., 2018), for two consecutive months, calls drop to monthly. The primary care clinician receives a one-line summary in the record after each change. Enrollment lasts 12 months. This design follows the telemonitoring and pharmacist management model tested in a cluster randomized trial in 16 Minnesota primary care clinics (Margolis et al., 2013).
Four Measures, Their Sources and Who Pulls Them
Table 1
Pilot Measures, Sources and Owners
| Measure | Definition | Source | Pulled by |
|---|---|---|---|
| Blood pressure control | Last office reading below 140/90 mm Hg at 12 months; denominator, all enrolled, including those who stop transmitting | Electronic health record vitals | Population health analyst |
| Change in home systolic pressure | Mean of the last two weeks of home readings minus the first two weeks | Telemonitoring platform | Lead pharmacist |
| Transmission adherence | Share of enrolled patients sending at least 6 readings in a given week | Telemonitoring platform | Lead pharmacist |
| Safety events | Potassium above 5.5 or creatinine rise of 30 percent or more after a medication change; emergency visits for low blood pressure or falls | Laboratory results and encounter records | Population health analyst |
Table 1 specifies the four measures. Each is reported quarterly for the 400 enrolled patients and for a comparison group of eligible patients at the seven clinics not in the pilot.
The Expected Effect and What Would Count as Failure
In the Minnesota trial, 57.2 percent of patients in the telemonitoring arm were under control at the 6-month and the 12-month checks, against 30.0 percent with usual care, with a systolic advantage close to 10 mm Hg over that year (Margolis et al., 2013). That trial included in-person pharmacist visits and a study team, so a lighter, telephone-based version in routine operations should expect less. The proposal therefore expects control at 12 months in 45 to 57 percent of enrolled patients, against an expected 30 percent in the comparison group, an absolute difference of roughly 15 to 27 percentage points. The pilot will count as a failure if the difference is under 10 points, or if safety events among enrolled patients exceed those in the comparison group.
Resources in Hours and Dollars
The main cost is pharmacist time. At an estimated 30 minutes per patient per month averaged across the year, 400 patients need about 2,400 pharmacist hours, or about 1.2 full-time pharmacists; with supervision and documentation, 1.5 full-time equivalents, about $195,000 a year in salary and benefits. Monitors and cellular hubs cost about $95 each, or $38,000, and the platform subscription about $6 per patient per month, or $28,800. Enrollment and teaching take 45 minutes of medical assistant time per patient, 300 hours in all. The total is about $262,000 plus the medical assistant hours, roughly $655 per enrolled patient, well below the $1,511 per patient the trial's more intensive version cost (Margolis et al., 2020).
The staff time comes from two places. Half a pharmacist position comes from the anticoagulation clinic, where warfarin monitoring visits have fallen as more patients take direct oral anticoagulants; one new position is requested. The proposal also stops two things for enrolled patients. Quarterly medical assistant recheck visits end, since home readings replace them, releasing about 530 hours a year, more than the 300 hours enrollment needs. Mailed recall letters for overdue blood pressure checks stop for this group, since the pharmacist is already in contact every two weeks.
The Two Largest Risks
The first risk is that patients stop transmitting. Home monitoring works only while readings arrive, and the patients in this population have already struggled with office follow-up. The response is built into the measures: any patient who sends no readings for two weeks gets a call from the medical assistant, not the pharmacist, to troubleshoot the device, and the adherence measure is reviewed monthly by the lead pharmacist so a falling trend is caught early.
The second risk is that the collaborative practice agreement is not signed in time, or is signed so narrowly that pharmacists must ask a physician before every change, which would slow titration to the pace of office visits. The response is to bring the protocol to the four clinics' physicians in October with the trial evidence and the safety measures attached, and to start enrollment only when the agreement allows the pharmacist to adjust at least the three most common drug classes without a separate order.
References
Margolis, K. L., Asche, S. E., Bergdall, A. R., Dehmer, S. P., Groen, S. E., Kadrmas, H. M., Kerby, T. J., Klotzle, K. J., Maciosek, M. V., Michels, R. D., O'Connor, P. J., Pritchard, R. A., Sekenski, J. L., Sperl-Hillen, J. M., & Trower, N. K. (2013). Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: A cluster randomized clinical trial. JAMA, 310(1), 46-56. https://doi.org/10.1001/jama.2013.6549
Margolis, K. L., Dehmer, S. P., Sperl-Hillen, J., O'Connor, P. J., Asche, S. E., Bergdall, A. R., Green, B. B., Nyboer, R. A., Pawloski, P. A., Trower, N. K., & Maciosek, M. V. (2020). Cardiovascular events and costs with home blood pressure telemonitoring and pharmacist management for uncontrolled hypertension. Hypertension, 76(4), 1097-1103. https://doi.org/10.1161/HYPERTENSIONAHA.120.15492
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr., . . . Wright, J. T., Jr. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71(6), e13-e115. https://doi.org/10.1161/HYP.0000000000000065
What the DNP 825 Topic 7 instructions ask for
Topic 7 in DNP-825 asks students to propose an intervention for a defined population. Strong proposals define the population to a count with explicit criteria, describe the intervention as who does what, to whom and how often, and specify measures with their data sources and the people who will produce them. Students should state the expected effect from the best available evidence and say in advance what result would count as failure. The proposal should estimate resources in hours and dollars, name the largest risks with a response to each and say what current work would stop, since committees ask that first.
How the DNP-825 Topic 7 example is put together
The finished example proposes something a committee could approve or decline. The population is defined to a count, the intervention is described at the level of who does what and when, and four measures are specified, each naming the system that holds it and the person able to pull it. The expected effect is stated as a range with the evidence it comes from, since a proposal promising improvement without saying how much cannot be evaluated. Resources appear in hours and dollars, including the staffing the intervention requires and where it comes from. The example also names what it will stop doing to free that time, which is the question every real proposal is asked and most academic ones ignore.
Where the marks sit in the DNP 825 Topic 7 rubric
Faculty reward a proposal a committee can decide on. An Excellent proposal defines 2,450 eligible adults using two readings at or above the 140/90 threshold and enrolls 400. Credit goes to specifying cellular monitors, pharmacist titration and contact frequency. The rubric values four measures with sources and owners, a comparison group at seven clinics and Margolis and colleagues' effect of 57.2 against 30.0 percent. Strong proposals cost about 2,400 pharmacist hours. Top marks go to defining failure in advance and planning for patients who stop transmitting. Risks get responses.
DNP 825 Topic 7 help before you submit
Proposals promising improvement with no expected magnitude are the standard version and cannot be evaluated afterward. A second failure is specifying measures nobody has confirmed are obtainable, which is discovered in the first month rather than in the proposal. Marks also go for describing resources in general terms, since a committee approves hours and money rather than intentions. Proposals that never say what will stop assume the staff time appears from nowhere. Populations defined too loosely to count cannot be planned or budgeted for. Plans with no failure criterion make it impossible to conclude the program did not work. Interventions described at the level of an aim rather than an activity cannot be staffed or scheduled. Risks named with no response attached leave a committee to work out the mitigation themselves.
Get a DNP-825 Topic 7 example written to your instructions
Send the DNP-825 Topic 7 instructions and the rubric your classroom posts, with the population and problem your section assigned. We write a custom example to those criteria, with the group defined to a count, measures carrying extraction owners, an expected effect range and resources including what stops, in 24 to 48 hours. The first is free.
More DNP 825 papers and DNP samples
- DNP 825 Topic 1: Population Thinking Paper
- DNP 825 Topic 2: Measure and Denominator Analysis
- DNP 825 Topic 3: Access Barrier Analysis
- DNP 825 Topic 4: Screening Program Analysis
- DNP 825 Topic 5: Policy Lever DQ Pair
- DNP 825 Topic 6: Language and Culture in Program Design
- DNP 825 Topic 8: Sustainability and Funding Analysis
- DNP 830 Topic 7: Results for a Practice Audience
- DNP 820 Topic 7: Translation Model Selection
- DNP 835 Topic 7: Sustainability Plan with Owners
- DNP 815A Topic 7: Framework Selection for Practice Problem
DNP 825 Topic 7 questions, answered
Why state an expected effect?
Because it makes the proposal evaluable and honest. A program predicted to improve control by three to six percentage points can be judged; one promising improved outcomes cannot. It also forces you to check whether the expected effect is worth the resources, and occasionally that arithmetic ends a proposal before it consumes a year.
What does it mean for a measure to be real?
That somebody could produce it next month. The field is populated, a report either exists or can be built, and whoever owns that data has already agreed. Measures that are real in principle and unavailable in practice look identical on paper and diverge completely once the program starts. Naming the extraction owner is the fastest way to prove the difference.
Why say what will stop?
Because it is the first question a committee asks and the one academic proposals most often skip. Staff hours are not created by approval. Naming what the team will stop doing, or what will be deferred, converts the proposal from a wish into a plan and tends to make the reviewers considerably more receptive.
Where can I find a free DNP 825 Topic 7 sample paper?
The intervention proposal for DNP 825 Topic 7 covers the population defined to a count, who does what, four measures with sources, the expected effect and what counts as failure, resources and the two largest risks. Paste in your DNP 825 Topic 7 prompt and a free proposal follows.
Why state an expected effect in DNP 825 Topic 7?
It makes the proposal evaluable. With the trial's 57.2 against 30.0 percent as the benchmark, the committee can see in advance what result would justify continuing.